From: Determinants of cough-related quality of life in interstitial lung diseases
Characteristics of ILD patients | LCQ total score (n = 110) | SGRQ total score (n = 99) |
---|---|---|
Age (years) Rs | 0.09 (p = 0.33) | 0.13 (p = 0.20) |
Gender: male (n = 68) female (n = 43) | 17.0 (13.4–18.6) 16.1 (12.0–19.0) (p = 0.81) | 31.1 (14.1–49.1) 31.5 (17.9–31.5) (p = 0.79) |
BMI (kg/m2) Rs | -0.28 (p = 0.004) | 0.32 (p = 0.001) |
Current smoking: yes (n = 13) no (n = 98) | 18.5 (13.4–19.6) 16.7 (13.1–18.5) (p = 0.19) | 23.8 (23.8–37.8) 31.5 (16.6–48.7) (p = 0.35) |
Ever smoking: yes (n = 67) no (n = 44) | 17.5 (13.4–19.0) 15.9 (12.0–18.4) (p = 0.31) | 26.6 (14.3–42.0) 33.5 (18.0–48.7) (p = 0.30) |
FVC (% predicted) Rs | 0.048 (p = 0.62) | -0.20 (p = 0.051) |
FEV1 (% predicted) Rs | 0.09 (p = 0.33) | -0.14 (p = 0.17) |
DLCO (% predicted) Rs | 0.51 (P = 0.60) | -0.27 (p = 0.007) |
Ground glass opacities Rs | -0.21 (p = 0.03) | 0.27 (p = 0.008) |
Granulomas: yes (n = 8) no (n = 103) | 12.7 (7.8–15.5) 16.9 (13.4–19.0) (p = 0.009) | 34.8 (29.8–56.7) 31.2 (14.9–43.6) (p = 0.21) |
Presence of any chronic cough comorbidities: yes (n = 26) no (n = 85) | 15.0 (12.7–18.0) 17.0 (13.4–19.0) (p = 0.20) | 34.8 (26.5–46.3) 26.8 (14.1–46.3) (p = 0.10) |
ACE inhibitor use: yes (n = 14) no (n = 96) | 16.3 (12.5–18.2) 16.8 (13.2–18.9) (p = 0.83) | 37.7 (23.9–69.1) 29.3 (15.1–43.1) (p = 0.09) |